These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 19928575)
21. Synthesis and Antiviral Evaluation of Some C(3)-Symmetrical Trialkoxy-Substituted 1,3,5-Triazines and Their Molecular Geometry. Mibu N; Yokomizo K; Aki H; Ota N; Fujii H; Yuzuriha A; Saneyoshi S; Tanaka A; Koga A; Zhou J; Miyata T; Sumoto K Chem Pharm Bull (Tokyo); 2015; 63(11):935-44. PubMed ID: 26521858 [TBL] [Abstract][Full Text] [Related]
22. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains. Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935 [TBL] [Abstract][Full Text] [Related]
23. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture. Schnitzler P; Schön K; Reichling J Pharmazie; 2001 Apr; 56(4):343-7. PubMed ID: 11338678 [TBL] [Abstract][Full Text] [Related]
24. Biological characterization of eugeniin as an anti-herpes simplex virus type 1 compound in vitro and in vivo. Kurokawa M; Hozumi T; Tsurita M; Kadota S; Namba T; Shiraki K J Pharmacol Exp Ther; 2001 Apr; 297(1):372-9. PubMed ID: 11259565 [TBL] [Abstract][Full Text] [Related]
25. Comparative study on the antiherpetic activity of aqueous and ethanolic extracts derived from Cajanus cajan (L.) Millsp. Zu Y; Fu Y; Wang W; Wu N; Liu W; Kong Y; Schiebel HM; Schwarz G; Schnitzler P; Reichling J Forsch Komplementmed; 2010 Mar; 17(1):15-20. PubMed ID: 20215758 [TBL] [Abstract][Full Text] [Related]
26. 1,2,4-Triazoloazine derivatives as a new type of herpes simplex virus inhibitors. Deev SL; Yasko MV; Karpenko IL; Korovina AN; Khandazhinskaya AL; Andronova VL; Galegov GA; Shestakova TS; Ulomskii EN; Rusinov VL; Chupakhin ON; Kukhanova MK Bioorg Chem; 2010 Dec; 38(6):265-70. PubMed ID: 20947122 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of herpes simplex virus type 1 entry by chloride channel inhibitors tamoxifen and NPPB. Zheng K; Chen M; Xiang Y; Ma K; Jin F; Wang X; Wang X; Wang S; Wang Y Biochem Biophys Res Commun; 2014 Apr; 446(4):990-6. PubMed ID: 24657267 [TBL] [Abstract][Full Text] [Related]
28. Proteinase inhibitors from Streptomyces with antiviral activity. Serkedjieva J; Angelova L; Remichkova M; Ivanova I J Basic Microbiol; 2006; 46(6):504-12. PubMed ID: 17139614 [TBL] [Abstract][Full Text] [Related]
29. S-adenosyl methionine decarboxylase activity is required for the outcome of herpes simplex virus type 1 infection and represents a new potential therapeutic target. Greco A; Callé A; Morfin F; Thouvenot D; Cayre M; Kindbeiter K; Martin L; Levillain O; Diaz JJ FASEB J; 2005 Jul; 19(9):1128-30. PubMed ID: 15863396 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of viral adsorption and penetration by an aqueous extract from Rhododendron ferrugineum L. as antiviral principle against herpes simplex virus type-1. Gescher K; Kühn J; Hafezi W; Louis A; Derksen A; Deters A; Lorentzen E; Hensel A Fitoterapia; 2011 Apr; 82(3):408-13. PubMed ID: 21129454 [TBL] [Abstract][Full Text] [Related]
31. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication. Varadinova T; Vilhelmova N; Badenas F; Terrón A; Fiol J; Garcia-Raso A; Genova P Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682 [TBL] [Abstract][Full Text] [Related]